I work on machine learning for biology, and I care most about models that explain why cells respond to a drug or perturbation the way they do, not only what they will do.
I recently joined Apheris as a machine learning researcher for molecular privacy. The work is about letting organizations study sensitive molecular data together without sharing any data, and I also contribute to Apheris’s virtual cell network. Before Apheris I spent about a year and a half at AI VIVO building generative models for drug discovery.
In parallel, from late 2022, I was a data scientist at the Wellcome Sanger Institute (Lotfollahi Lab), where I co-first-authored CellDISECT (bioRxiv 2025; under review at Nature Biomedical Engineering), co-authored SP-FM (arXiv 2026), fine-tuned single-cell foundation models for perturbation prediction, and was lead maintainer of CPA.
Applied Computer Science & Artificial Intelligence, 2026
Sapienza University of Rome
BSc in Computer Science, 2023
Amirkabir University of Technology

A flow-matching method whose starting distribution depends on the condition, which helps conditional generative models extrapolate to unseen conditions.